Abstract

Alzheimer's disease (AD) represents the most widespread form of age-related cognitive degeneration, characterized by long-term degenerative damage, cognitive dysfunction, and profound deficits in logical thinking, knowledge acquisition, and interpersonal communication. A principal biomarker of AD involves the emergence and aggregation of (3-amyloid (A(3). Cranad derivatives are fluorescent probes capable of detecting, quantifying, and imaging A(3 aggregates. In this work, the effect of solvent and microheterogeneous environments on the photophysical behavior of CRANAD-2 and CRANAD-58 was investigated employing a large solvent set and several microorganized systems. Both the absorption and fluorescence spectra exhibit a substantial solvatochromic effect, resulting in significant Stokes shifts. Application of linear solvation energy relationships to correlate the fluorescence spectra maxima and the Stokes shift with microscopic solvent parameters suggests significant intramolecular charge transfer during the excitation, as corroborated by the increased dipole moment in the excited state. Generally, fluorescence quantum yields determined for CRANAD-2 exceed those of CRANAD58 in most solvents, with low values in polar solvents and bigger values in non-polar solvents. Introduction of CRANAD-2 and CRANAD-58 into micellar and vesicular solutions notably augments the fluorescence emission intensity, accompanied by a blue shift in the fluorescence maxima. The fluorescence maxima values observed within microheterogeneous systems closely parallel those reported for interactions between CRANAD derivatives and soluble or aggregated A(3 amyloids which potentially constrains the efficacy of "in vivo" A(3 detection trials, because localization of CRANAD derivatives in non-polar microenvironments present in biological media could interfere with the detection of amyloid fibers.